Immunoglobulin heavy locus (IGH)

The Immunoglobulin heavy locus (IGH) is a complex genomic region located on chromosome 14 (14q32.33) in humans that encodes the heavy chain components of all antibody classes (HGNC:5477). It consists of multiple variable (V), diversity (D), joining (J), and constant (C) gene segments that undergo somatic V(D)J recombination and class-switch recombination to generate a diverse repertoire of antibodies essential for the adaptive immune response (NCBI Gene: 3492). While not a traditional protein drug target, the IGH locus is clinically significant as a site of frequent chromosomal translocations in B-cell malignancies, such as the t(14;18) translocation in follicular lymphoma and the t(8;14) in Burkitt lymphoma (PubMed: 25239236). Additionally, the mutational status of the IGH variable region (IGHV) serves as a critical prognostic biomarker in chronic lymphocytic leukemia (CLL) (PubMed: 10506550). Therapeutic strategies typically focus on the protein products of this locus or the B-cells expressing them rather than the genomic locus itself. Understanding the structural variations and rearrangements within this locus is vital for diagnosing and monitoring various hematological cancers. The locus is also involved in primary immunodeficiency disorders when deletions or mutations occur in the constant regions (OMIM: 147100). Modern genomic editing techniques like CRISPR/Cas9 are being explored to target this locus for therapeutic antibody production or to correct genetic defects, though these are largely experimental.

Other names

IGH@IGHIGHCIGHVIGHDIGHJImmunoglobulin heavy chain locus

Not applicable as a direct drug target; however, it serves as a site for chromosomal translocations and a marker for B-cell clonal expansion.